Document is current
Any future updates will be listed below
-
Authors
Celis-Preciado, Carlos Andrés https://orcid.org/0000-0001-8405-4513
Leclerc, Simon https://orcid.org/0009-0003-0936-5647
Duval, Martine
Cliche, Dominic O.
Larivée, Pierre https://orcid.org/0009-0000-9600-9533
Lemaire-Paquette, Samuel
Lévesque, Simon https://orcid.org/0000-0002-4356-9702
Côté, Andréanne https://orcid.org/0000-0001-5653-4931
Lachapelle, Philippe https://orcid.org/0000-0001-9290-1823
Couillard, Simon https://orcid.org/0000-0002-4057-6886
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05870215 at ClinicalTrials.govnct05304039 at ClinicalTrials.govDocuments that mention this clinical trial
Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study
https://doi.org/10.1136/bmjresp-2023-001932
nct04293588 at ClinicalTrials.govDocuments that mention this clinical trial
Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study
https://doi.org/10.1136/bmjresp-2023-001932
Documents that mention this clinical trial
Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study
https://doi.org/10.1136/bmjresp-2023-001932
-
Funding
Funding for this research was provided by:
Association Pulmonaire du Québec’s Research Chair in respiratory medicine
bioMérieux investigator-initiated research grant
Quebec Respiratory Health Research Network research grant
Fonds de recherche du Québec
Sanofi-Regeneron Global Innovation Grant Pathways in Type 2 Inflammation
- License Information
